Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy

<div>Early versus late recurrence. (a) Cumulative progression-free survival rate from the first chemotherapy cycle and (b) 5-year overall survival rate from the first chemotherapy cycle calculated using the Kaplan–Meier method.</div>

Journal of Oncology

fig2

Figure 2

Figure 2: Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy 

Figure 2 | Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy 